Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Trastuzumab in Metastatic Breast Cancer
NCT00134680Phase 2Completed
- Sponsor
- Duke University
- Start
- Jan 2000
- Primary completion
- Jan 2005
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole, trastuzumab in breast cancer, sponsored by Duke University. Started Jan 2000; status: completed.
02
Drugs
letrozoletrastuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00134680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134680.